Ambrx Biopharma - Stock Price History | AMAM

Historical daily share price chart and data for Ambrx Biopharma since 2021 adjusted for splits. The latest closing stock price for Ambrx Biopharma as of October 15, 2021 is 12.47.
  • The all-time high Ambrx Biopharma stock closing price was 22.53 on July 13, 2021.
  • The Ambrx Biopharma 52-week high stock price is 22.87, which is 83.4% above the current share price.
  • The Ambrx Biopharma 52-week low stock price is 11.04, which is 11.5% below the current share price.
  • The average Ambrx Biopharma stock price for the last 52 weeks is 17.18.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Ambrx Biopharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.431B $0.014B
Ambrx Biopharma Inc. is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. Ambrx Biopharma Inc. is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $128.216B 8.54
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.812B 20.00
Biohaven Pharmaceutical Holding (BHVN) United States $8.815B 0.00
Emergent Biosolutions (EBS) United States $2.763B 6.66
Arcus Biosciences (RCUS) United States $2.321B 0.00
Myovant Sciences (MYOV) United Kingdom $1.993B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.769B 0.00
Zymeworks (ZYME) Canada $1.152B 0.00
SQZ Biotechnologies (SQZ) United States $0.346B 0.00
Enzo Biochem (ENZ) United States $0.188B 18.43